New hope for Treatment-Resistant schizophrenia? phase 3 trial launches
NCT ID NCT07184619
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests an experimental drug called evenamide for people with schizophrenia that hasn't improved with standard antipsychotics. About 400 adults will receive either evenamide or a placebo added to their current medication for 12 weeks. The goal is to see if evenamide reduces symptoms like hallucinations and delusions better than placebo, and to check its safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Ahana Hospitals LLP
RECRUITINGMadurai, Tamil Nadu, 625020, India
-
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
SUSPENDEDBaltimore, Maryland, 21224, United States
-
Gauhati Medical College and Hospital
RECRUITINGGuwahati, Assam, 781032, India
-
Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
SUSPENDEDAtlanta, Georgia, 30322, United States
-
Help Hospital
RECRUITINGVijayawada, Andhra Pradesh, 520002, India
-
Hospital Tuanku Fauziah
RECRUITINGKangar, 01000, Malaysia
-
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research
SUSPENDEDNew York, New York, 10035, United States
-
Masina Hospital Trust
RECRUITINGMumbai, Maharashtra, 400027, India
-
New Manak Healthcare Hospital
RECRUITINGNavi Mumbai, Maharashtra, 400706, India
-
Sentosa Hospital
RECRUITINGKuching, 93250, Malaysia
-
Seth Sukhlal Karnani Memorial Hospital
NOT_YET_RECRUITINGKolkata, West Bengal, 700025, India
-
Sultan Abdul Halim Hospital
RECRUITINGSungai Petani, 08000, Malaysia
-
UCLA DGSOM, UCLA Health, UCLA Semel Institute
SUSPENDEDLos Angeles, California, 90095, United States
-
Udyan Health Care
RECRUITINGLucknow, Uttar Pradesh, 226012, India
-
University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital
SUSPENDEDMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common food preservative help treat Hard-to-Treat schizophrenia?
- Brain pacemaker trial aims to quiet voices in Treatment-Resistant schizophrenia
- Brain pacemaker tested for untreatable schizophrenia
- Old drug, new hope: could acetazolamide ease tough schizophrenia symptoms?
- Sound waves aimed at brain may quiet schizophrenia symptoms
- New combo therapy aims to ease tough schizophrenia symptoms